Showing posts with label equity. Show all posts
Showing posts with label equity. Show all posts

Wednesday, July 26, 2023

If artificial intelligence uses your work, it should pay you; The Washington Post, July 26, 2023

If artificial intelligence uses your work, it should pay you

"Renowned technologists and economists, including Jaron Lanier and E. Glen Weyl, have long argued that Big Tech should not be allowed to monetize people’s data without compensating them. This concept of “data dignity” was largely responding to the surveillance advertising business models of companies such as Google and Facebook, but Lanier and Weyl also pointed out, quite presciently, that the principle would only grow more vital as AI rose to prominence...

When I do a movie, and I sign my contract with a movie studio, I agree that the studio will own the copyright to the movie. Which feels fair and non-threatening. The studio paid to make the movie, so it should get to monetize the movie however it wants. But if I had known that by signing this contract and allowing the studio to be the movie’s sole copyright holder, I would then be allowing the studio to use that intellectual property as training data for an AI that would put me out of a job forever, I would never have signed that contract."

Sunday, June 18, 2023

The future of open educational resources; Community College Daily, April 27, 2023

James Glapa-Grossklag is dean of educational technology, learning resources and online education at College of the Canyons (California).

Una Daly is director of the Community College Consortium for Open Educational Resources (CCCOER) at Open Education Global, Community College Daily; The future of open educational resources

"The future of OER is that it will not be the next big thing, but rather that OER will be a common way for students to freely access information, a tool in the enrollment management toolkit, and a commitment to equitable outcomes and collaborative teaching."

Friday, November 19, 2021

Barbara Ringer’s Legacy of Fighting for Equity at the Copyright Office: An Interview with Amanda Levendowski; Library of Congress, November 19, 2021

, Library of Congress ; Barbara Ringer’s Legacy of Fighting for Equity at the Copyright Office: An Interview with Amanda Levendowski

"Forty-eight years ago today, November 19, Barbara Ringer was appointed the Copyright Office’s first female Register of Copyrights. She spent her career fighting for equity within the Office and beyond and led the way for the four women who have since served in the role. In 1995, the Library of Congress awarded Ringer its Distinguished Service Award in recognition of her lifetime contributions to the field of copyright and the Library.

To commemorate Ringer’s legacy, I spoke with Amanda Levendowski, associate professor of law at Georgetown Law and the founding director of the Intellectual Property and Information Policy (iPIP) Clinic, about the inspiration Barbara Ringer provides to those in the field of copyright. Through articles and events, Levendowski has shined a light on a visionary leader who continues to inspire current and future intellectual property professionals."

Wednesday, November 10, 2021

International exchange: Promoting the inclusion of women in intellectual property; United States Patent and Trademark Office (USPTO), November 16, 2021 4 PM - 6 PM ET

United States Patent and Trademark Office (USPTO); International exchange: Promoting the inclusion of women in intellectual property

"Studies of patent data conducted by the World Intellectual Property Organization (WIPO), the United States Patent and Trademark Office (USPTO), and others have shown that women inventors are significantly underrepresented in the patent system worldwide. Despite an increased number of women entering the science, technology, engineering, and math (STEM) fields in recent years, there is still a large gap between the number of women entering these fields and men. This has led to fewer women participating in the intellectual property (IP) system overall.

Register today to hear presentations by representatives of IP offices from around the world, who will discuss these trends and explain how some countries have succeeded in increasing the participation rate of women in their IP systems. Topics will include:

  • Strategies for increasing the participation of women in the IP system
  • How to recruit, retain, and promote women in IP fields

You will hear from leading officials from the USPTO, IP Australia, the Canadian IP Office, the IP Office of the Philippines, the Mexican Institute of Industrial Property, the IP Office of New Zealand, the Industrial Property Protection Directorate of Jordan, and other national offices."

Tuesday, July 4, 2017

Louisiana considers radical step to counter high drug prices: Federal intervention; Washington Post, July 3, 2017

Carolyn Y. Johnson, Washington Post; Louisiana considers radical step to counter high drug prices: Federal intervention

"At [Louisiana’s health secretary Rebekah] Gee’s urging, Joshua Sharfstein, a professor of public health at Johns Hopkins University and a former Food and Drug Administration deputy commissioner, convened a meeting of health-policy specialists and economists. They advised that the state ask the federal government to intervene in a two-pronged approach: Gee should first ask the government to negotiate with a drug company and license a medication, in line with a recent recommendation by a committee from the National Academies.

At the same time, they advised Gee to pursue a harder-edged tactic, in case the voluntary approach did not work: Gee should ask the secretary of health and human services to invoke a century-old law that allows the government to use patents at a reasonable cost. The panel recommended a price as low as $1,000 per patient.

The law was used routinely in the 1950s and 1960s to make medicines available at lower prices. It was considered but not used during the anthrax attacks in 2001. It has been used by more than 10 government agencies or departments to lower the prices for patented inventions, including night-vision goggles for the Defense Department.

“The drug has been out for years, and we’re failing to provide it to the majority of people who have this infection,” Gee said. “We’re failing at our mission to improve the public health, and so just doing what we’re doing is not an option and we have to do better.”"